Biokit USA, located in Lexington, MA, is a subsidiary of Werfen, a global leader in the in vitro diagnostics sector. With a presence in over 30 countries and more than 100 territories, Biokit USA specializes in developing innovative diagnostic systems and services for laboratories and hospitals worldwide, focusing on areas such as hemostasis, acute care diagnostics, transfusion, autoimmunity, and transplantation.
Driven by a passion for enhancing patient care and creating healthier societies, Biokit USA combines innovation and quality to provide high-quality diagnostic solutions that improve the quality of patient outcomes. As part of the Werfen family, Biokit USA is committed to leveraging its expertise and talented workforce to meet the evolving needs of the healthcare industry.
Generated from the website